A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
Beijing Dongfang Biotech Co., Ltd. · Type 2 Diabetes Mellitus
Phase 3
Active, not recruiting
270
2025-09
Industry sponsor intelligence
Beijing Dongfang Biotech Co., Ltd.Clinical Pipeline.
Lead-sponsor view of Beijing Dongfang Biotech Co., Ltd.'s indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 3
- Recruiting
- 0
- Active
- 2
- Completed
- 1
- Results posted
- 0
- Avg enrollment
- 299
Pipeline overview
Programs by phase and activity.
Velocity
Beijing Dongfang Biotech Co., Ltd. trials by start year
Study start year · indexed snapshot
Development
Trials by phase
3phase labels
Early Phase 10
Phase 11
Phase 20
Phase 32
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Exenatide → | 3 | 1 | 0 | 2 | 0 | 2 |
| Dulaglutide → | 1 | 0 | 0 | 1 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
Beijing Dongfang Biotech Co., Ltd. · Type2 Diabetes Mellitus
Phase 3
Active, not recruiting
600
2025-09
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjects
Beijing Dongfang Biotech Co., Ltd. · Diabetes Mellitus, Type 2 · Overweight
Phase 1
Completed
28
2024-08
Search sponsor records
All Beijing Dongfang Biotech Co., Ltd. studies.
This page groups studies where Beijing Dongfang Biotech Co., Ltd. is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
3 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT06254014A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM PatientsSep 18, 2025NCT06257966A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With MetforminSep 17, 2025NCT06247748Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese SubjectsAug 21, 2024